Differentiating idiopathic inflammatory myopathies from metabolic myopathies

Rheumatic Disease Clinics of North America

Volumn 28, Issue 4, 2002, Pages 759-778

  Wortmann, Robert L ^a   DiMauro, Salvatore ^b  

^a Univ of OK Coll of Medicine Tulsa   (United States)

^b 4 420 College of Physicians/Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; CARNITINE; CARNITINE PALMITOYLTRANSFERASE; MITOCHONDRIAL ENZYME; UBIDECARENONE; VERY LONG CHAIN FATTY ACID;

ADOLESCENT; ADULT; CARBOHYDRATE METABOLISM; CARDIOMYOPATHY; CHILD; DIFFERENTIAL DIAGNOSIS; ELECTROMYOGRAM; ELECTRON MICROSCOPY; HUMAN; INFLAMMATORY DISEASE; LIMB GIRDLE MUSCULAR DYSTROPHY; LIPID METABOLISM; METABOLIC DISORDER; MITOCHONDRIAL MYOPATHY; MITOCHONDRION; MUSCLE BIOPSY; MUSCLE DISEASE; MUSCLE WEAKNESS; MYOGLOBINURIA; MYOPATHY; POLYMYOSITIS; PRIORITY JOURNAL; REVIEW;

DIAGNOSIS, DIFFERENTIAL; EXERCISE TEST; GLYCOGEN; HUMANS; LIPID METABOLISM; METABOLIC DISEASES; MITOCHONDRIAL MYOPATHIES; MUSCLE, SKELETAL; MYOSITIS;

EID: 0036866888     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(02)00022-4     Document Type: Review

References (85)

1. DiMauro S, Lamperti C. Muscle glycogenesis. Muscle Nerve 2001;24:984-99.
2. Miró O, Laaguno M, Masanés F, et al. Congenital and metabolic myopathies of childhood or adult onset. Semin Arthritis Rheum 2000;29:335-47.
3. Nardin RA, Johns DR. Mitochondrial dysfunction and neuromuscular disease. Muscle Nerve 2001;24:170-91.
4. Simon DK, Johns DR. Mitochondrial disorders: Clinical and genetic features. Annu Rev Med 1999;50:111-27.
5. Vladutiu GD. The molecular diagnosis of metabolic myopathies. Neurol Clin 2000;18(1):53-104.
6. Wortmann RL. Metabolic and mitochondrial myopathies. Curr Opin Rheumatol 1999;11(6):462-7.
7. Wortmann RL. Metabolic disease of muscle. In: Wortmann RL, editor. Diseases of Skeletal Muscle. Philadelphia: Lippincott, Williams & Wilkins; 2000. p. 157-87.
8. Wortmann RL. Myositis or myopathy. J Rheumatol 1989;16(12):1525-7.
9. Wortmann RL. Skeletal muscle biology, physiology, and biochemistry. In: Wortmann RL, editor. Diseases of Skeletal Muscle. Philadelphia: Lippincott, Williams & Wilkins; 2000. p. 11-22.
10. Johnston W, Karpati G, Carpenter S, et al. Late-onset mitochondrial myopathy. Ann Neurol 1995;37:16-23.
11. Danon MJ, Servidei S, DiMauro S, et al. Late-onset muscle phosphofructokinase deficiency. Neurology 1988;38(6):956-60.
12. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-407.
13. Bohan A, Peter JB, Bowman RL, et al. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977;56:255-86.
14. Higgs JB, Blaivas M, Albers JW. McArdle's disease presenting as treatment resistant polymyositis. J Rheumatol 1989;16:1587-90.
15. Morgan-Hughes JA, Schapira AH, Cooper JM, et al. The molecular pathology of respiratory chain dysfunction in human mitochondrial myopathies. Biochem Biophys Acta 1990;1018:217-22.
16. Pearson CM. Patterns of polymyositis and their response to treatment. Ann Intern Med 1963;59(6):827-38.
17. Ionin P, Lewis P, Servidei S, et al. Metabolic causes of myoglobinuria. Ann Neurol 1990;27:181-5.
18. Comelio F, Bresolin N, DiMauro S, et al. Congenital myopathy due to phosphorylase deficiency. Neurology 1983;33:1383-5.
19. Braakhakke JP, de Bruin MI, Stegeman DF, et al. The second wind phenomenon in McArdle's disease. Brain 1986;109:1087-101.
20. DiMauro S, Hartlage P. Fatal infantile form of muscle phosphorylase deficiency. Neurology 1978;28:1124-9.
21. El-Schahawi M, Bruno C, Tsujino S, et al. Sudden infant death syndrome (SIDS) in a family with myophosphorylase deficiency. Neuromuscul Disord 1997;7:81-3.
22. Milstein JM, Herron TM, Haas JE. Fatal infantile muscle phosphorylase deficiency. J Child Neurol 1989;4:186-8.
23. DiMauro S, Tsujino S. Nonlysosomal glycogenoses. In: Engel AG, Franzini-Armstrong C, editors. Myology. 2nd Edition. New York: McGraw-Hill; 1994. p. 1554-76.
24. Hays AP, Hallett M, Delfs J, et al. Muscle phosphofructokinase deficiency: Abnormal polysaccharide in a case of late-onset myopathy. Neurology 1981;31:1077-86.
25. Sivakumar J, Vasconeelos O, Goldfarb L, et al. Late-onset muscle weakness in partial phosphofructokinase deficiency: A unique myopathy with vacuolar, abnormal mitochondria, and an absence of the common exon 5/intron5 junction point mutation. Neurology 1996;46:1337-42.
26. Haller RG, Lewis SF. Glucose-induces exertional fatigue in muscle phosphofructokinase deficiency. N Engl J Med 1991;324:364-9.
27. Wilkinson DA, Tonin P, Shanske S, et al. Clinical and biochemical features of 10 adult patients with muscle phosphorylase kinase deficiency. Neurology 1994;44:461-6.
28. DiMauro S, Dalakas M, Miranda AF. Phosphoglycerate kinase deficiency: Another cause of recurrent myoglobinuria. Ann Neurol 1983;13:11-9.
29. Hamano T, Mutoh T, Sugie H, et al. Phosphoglycerate kinase deficiency: An adult myopathic form with a novel mutation. Neurology 2000;54:1188-90.
30. DiMauro S, Miranda AF, Khan S, et al. Human muscle phosphoglycerate mutase deficiency: Newly discovered metabolic myopathy. Science 1981;212:1277-9.
31. Kanno T, Sudo K, Takeuchi I, et al. Hereditary deficiency of lactate dehydrogenase M-subunit. Clin Chim Acta 1980;108:267-76.
32. Kreuder J, Borkhardt A, Repp R, et al. Inherited metabolic myopathy and hemolysis due to a mutation in aldolase A. N Engl J Med 1996;334:1100-4.
33. Comi GP, Fortunato F, Lucchiari S, et al. B-enolase deficiency, a new metabolic myopathy of distal glycolysis. Neurology 2001;56(Suppl 3):A231-2.
34. Engel AG, Hirschom R. Acid maltase deficiency. In: Engel AG, Franzini-Armstrong C, editors. Myology. 2nd Edition. New York: McGraw-Hill; 1994. p. 1533-76.
35. Slonim AE, Balone L, Ritz S, et al. Identification of two subtypes of infantile acid maltase deficiency. J Pediatr 2000;137:283-5.
36. Bomemann A, Besser R, Shin YS, et al. A mild adult myopathic variant of type IV glycogenosis. Neuromuscul Disord 1996;6:95-9.
37. Reusche E, Aksu F, Goebel HH, et al. A mild juvenile variant of type IV glycogenosis. Brain Dev 1992;14:36-43.
38. DiMauro S, Hartwig GB, Hays AP, et al. Debrancher deficiency: Neuromuscular disorder in five adults. Ann Neurol 1979;5:422-36.
39. Kiechi S, Kohlendorfer U, Thaler C, et al. Different clinical aspects of debrancher deficiency myopathy. J Neurol Neurosurg Psychiatry 1999;67:364-8.
40. Marbini A, Gemignani F, Saccardi F, et al. Debrancher deficiency neuromuscular disorder with pseudohypertrophy in two brothers. J Neurol 1989;236:418-20.
41. Carrier HM, Berhillier G. Camitine levels in normal children and adults and in patients with diseased muscle. Muscle Nerve 1990;3:326-34.
42. Rebouche CJ, Paulson DJ. Camitine metabolism and function in humans. Annu Rev Nutr 1986;6:41-66.
43. Turnbull DM, Bartlett K, Stevens DL, et al. Short-chain acyl-CoA dehydrogenase deficiency associated with lipid-storage myopathy and secondary camitine deficiency. N Engl J Med 1984;311(19):1232-6.
44. Hale DE, Batshaw ML, Coates PM, et al. Long-chain acyl-CoA dehydrogenase deficiency: An inherited cause of non-ketotic hypoglycemia. Pediatr Res 1985;19:666-71.
45. DiDonato S, Taroni F, Gellera C, et al. Long-chain acyl-CoA dehydrogenase deficiency in muscle in an adult with lipid myopathy. Neurology 1988;38:269A-71A.
46. Turnbull DM, Shepherd IM, Ashworth B, et al. Lipid storage myopathy associated with low acyl-CoA dehydrogenase activities. Brain 1988;111:815-28.
47. Bardosi A, Scheidt P, Goebel H. Mitochondrial myopathy: A result of clofibrate/etiofibrate treatment? Acta Neuropathol (Berl) 1985;68:164-8.
48. Chariot P, Monnet I, Mouchet M, et al. Determination of the blood lactate: Pyruvate ratio as a noninvasive test for the diagnosis of zidovudine myopathy. Arthritis Rheum 1994;37:583-6.
49. Simpson MV, Chin CD, Keilbaugh SA, et al. Studies on the inhibition of mitochondrial DNA replication by 3′azido-3′-deoxythymidine and other dideoxynucleoside analogs which inhibit HIV-I replication. Biochem Pharm 1989;38:1033-6.
50. Blume G, Pestronk A, Frank B, et al. Polymyositis with cytochrome oxidase negative muscle fibers: Early quadriceps weakness and poor response to immunosuppressive therapy. Brain 1997;120:39-45.
51. Harle JR, Pellissier JF, Desnuelle C, et al. Polymyalgia rheumatica and mitochondrial myopathy: Clinicopathologic and biochemical studies in five cases. Am J Med 1992;92:167-72.
52. Levine TD, Pestronk A. Inflammatory myopathy with cytochrome oxidase negative muscle fibers: Methotrexate treatment. Muscle Nerve 1998;21:1724-8.
53. Oldfors A, Moselemi RA, Fyhr IM, et al. Mitochondrial DNA deletions in muscle fibers in inclusion body myositis. J Neuropathol Exp Neurol 1995;54:581-7.
54. Reichmann H, Schalke B, Seibel P, et al. Sarcoid myopathy and mitochondrial respiratory chain defects: Clinicopathological, biochemical, and molecular biological analyses. Neuromuscul Disord 1995;5:277-83.
55. Hudgson P, Bradley W, Jenkinson M. Familial mitochondrial myopathy. Part I. Clinical, electrophysiological and pathological findings. J Neurol Sci 1974;16:343-70.
56. Julien V, Vital C, Vallat J, et al. Oculopharyngeal muscular dystrophy: A case with abnormal mitochondrial and fingerprint inclusions. J Neurol Sci 1974;21:164-9.
57. Jackson MJ, Schaefer JA, Johnson MA, et al. Presentation and clinical investigation of mitochondrial respiratory chain disease. A study of 51 patients. Brain 1995;118:339-57.
58. Petty RK, Harding AE, Morgan-Hughes JA. The clinical features of mitochondrial myopathy. Brain 1986;109:915-38.
59. Mullie MA, Harding AE, Petty RK, et al. The retinal manifestations of mitochondrial myopathy. A study of 22 cases. Arch Ophthalmol 1985;103:1825-30.
60. Nishino I, Seki A, Maegaki Y, et al. A novel mutation in the mitochondrial tRNA(Thr) gene associated with a mitochondrial encephalomyopathy. Biochem Biophys Res Commun 1996;225:180-5.
61. Shaag A, Saada A, Steinberg A, et al. Mitochondrial encephalomyopathy associated with a novel mutation in the mitochondrial tRNA(leu)(UUR) gene (A3243T). Biochem Biophys Res Commun 1997;233:637-9.
62. Martin A, Haller RG, Barohn R. Metabolic myopathies. Curr Opin Rheumatol 1994;6:552-8.
63. DiMauro S, Moraes CT. Mitochondrial encephalomyopathies. Arch Neurol 1993;50:1197-208.
64. Tein I, DiMauro S, Devivo PC. Recurrent childhood myoglobinuria. Adv Pediatr 1990;37:77-117.
65. Bolin Jr P. Rhabdomyolysis. In: Wortmann RL, editor. Diseases of Skeletal Muscle. Philadelphia: Lippincott, Williams & Wilkins; 2000. p. 245-52.
66. Poggi-Travert F, Martin D, Billette de Villemeur T, et al. Metabolic intermediates in lactic acidosis: Compounds, samples, and interpretation. J Inher Metab Dis 1996;19:478-88.
67. Valen PA, Nakayama DA, Veum J, et al. Myoadenylate deaminase deficiency and forearm ischemic exercise testing. Arthritis Rheum 1987;30:661-8.
68. Morisaki T, Gross M, Morisaki H, et al. Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc Natl Acad Sci USA 1992;89:6457-61.
69. Mahowald ML, David WS. Electrophysiologic evaluation of muscle disease. In: Wortmann RL, editor. Diseases of Skeletal Muscle. Philadelphia: Lippincott, Williams & Wilkins; 2000. p. 313-31.
70. Wortmann RL, Vladutiu GD. The clinical laboratory evaluation of the patient with noninflammatory myopathy. Curr Rheumatol Reports 2001;3:1-7.
71. Robinson LR. American Association of Electrodiagnostic Medicine case report #22: Polymyositis. Muscle Nerve 1991;14(4):310-5.
72. Park JH, Olsen NG. Skeletal muscle imaging for the evaluation of myopathies. In: Wortmann RL, editor. Diseases of Skeletal Muscle. Philadelphia: Lippincott, Williams & Wilkins; 2000. p. 293-312.
73. Fleckenstein JL, Peshock RM, Lewis SF, et al. Magnetic resonance imaging of muscle injury and atrophy in glycolytic myopathies. Muscle Nerve 1989;12:849-55.
74. Fleckenstein JL, Haller RG, Lewis SF, et al. Absence of exercise-induced MRI enhancement of skeletal muscle in McArdle's disease. J Appl Physiol 1991;71:961-9.
75. Fleckenstein JL, Haller RG, Girson MS, et al. Focal muscle lesions in mitochondrial myopathy: MR imaging and evaluation. J Magn Reson Imaging 1992;2 [Suppl]:121.
76. Cinnamon J, Slonim AE, Black KS, et al. Evaluation of the lumbar spine in patients with glycogen storage disease: CT demonstration of patterns of paraspinal muscle atrophy. Am J Neuroradiol 1991;12:1099-103.
77. de Jager AE, van der Vliet TM, van der Ree TC, et al. Muscle computed tomography in adult-onset acid maltase deficiency. Muscle Nerve 1998;21:398-400.
78. Bossen EH. Muscle biopsy. In: Wortmann RL, editor. Diseases of Skeletal Muscle. Philadelphia: Lippincott, Williams & Wilkins; 2000. p. 333-48.
79. Engel AG. The muscle biopsy. In: Engel AG, Franzini-Armstrong C, editors. Myology. 2nd Edition. New York: McGraw-Hill; 1994. p. 822-31.
80. DiMauro S, Arnold S, Miranda AF, et al. McArdle disease: The mystery of reappearing phosphorylase activity in muscle culture. A fetal isoenzyme. Ann Neurol 1978;3:60-6.
81. Trijbels JMF, Sengers RCA, Ruitenbeek W, et al. Disorders of the mitochondrial respiratory chain: Clinical manifestations and diagnostic approach. Eur J Pediatr 1988;148:92-7.
82. Chretien D, Rustin P, Bourgeron T, et al. Reference charts for respiratory chain activities in human tissues. Clin Chim Acta 1994;228:53-70.
83. Zheng X, Shoffner JM, Voljavec AS, et al. Evaluation of procedures for assaying oxidative phosphorylation enzyme activities in mitochondrial myopathy muscle biopsies. Biochem Biophys Acta 1990;1019:1-10.
84. Bartram C, Edwards R, Clague J, et al. McArdle's disease: A nonsense mutation in exon 1 of the muscle glycogen phosphorylase gene explains some but not all cases. Hum Mol Genet 1993;2:1291-3.
85. El-Schahawi M, Tsujino S, Shanske S, et al. Diagnosis of McArdle's disease by molecular genetic analysis of blood. Neurology 1996;47:579-80.